B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ND4

MOLECULAR TARGET

NADH dehydrogenase subunit 4

UniProt: P03905NCBI Gene: 45382 compounds

ND4 (NADH dehydrogenase subunit 4) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ND4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Daunorubicin0.691
2Rotenone0.691

About ND4 as a Drug Target

ND4 (NADH dehydrogenase subunit 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented ND4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ND4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.